“We’re confident about that,” says Sabrina Maniscalco, Algorithmiq’s co-founder and chief executive, and a physicist at the University of Helsinki.
Some firms are so optimistic that they are even promising useful commercial applications in the near future. Helsinki-based start-up Algorithmiq, for instance, says it will be able to demonstrate practical quantum advances in drug development and discovery in five years’ time. “We’re confident about that,” says Sabrina Maniscalco, Algorithmiq’s co-founder and chief executive, and a physicist at the University of Helsinki.